Back to results
US 2021/0332019 A1Published application
Bicyclic Compound as a Caspase Inhibitor
AssigneeChia Tai Tianqing Pharmaceutical Group Co., Ltd.
InventorsJianfeng MOU, Songliang WU, Haiying HE, Fengying GUO, Chuan WANG, Jie LI, Jian LI, Shuhui CHEN
Life of this patent
Estimating the term…
Abstract
A compound represented by formula (I), a pharmaceutically acceptable salt or tautomer thereof, and an application of the compound as a caspase inhibitor.
Claims21
A compound represented by formula (I), a pharmaceutically acceptable salt or tautomer thereof,
- wherein,
- ring A is selected from a 5- or 6-membered heteroaryl group which is optionally substituted with ring B is selected from phenyl or C3-6 cycloalkyl, which is optionally substituted with R;
- R is selected from halogen, OH, NH2, or a C1-3 alkyl group optionally substituted with 1, 2 or 3 R1;
- R1 is selected from F, Cl, Br, I, OH, NH2, NH(CH3) or N(CH3)2.
1 more element
(canceled)
Dependencies are inferred from the claim text.